Zhejiang Jolly Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
July 27, 2021 at 08:10 am EDT
Share
Zhejiang Jolly Pharmaceutical Co.,LTD announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 697.672 million compared to CNY 466.789 million a year ago. Operating income was CNY 106.171 million compared to CNY 35.652 million a year ago. Net income was CNY 86.560 million compared to CNY 30.706 million a year ago. Basic earnings per share from continuing operations was CNY 0.1422 compared to CNY 0.0505 a year ago.
Zhejiang Jolly Pharmaceutical Co., Ltd. is a China-based company principally engaged in research, development, manufacture and sales of medicinal fungi series products. The Companyâs main business is mainly involved in pharmaceutical manufacturing, among which the activities are involved in manufacture and sale of active pharmaceutical ingredients, tablets, capsules, granules, Lyophilized powders and other products. The main products include Wuling series, bailing tablets series and Chinese medicine drinking tablets series, among others. Through its subsidiaries, the Company is also engaged in pharmaceutical circulation.
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD 
